The invention described herein is a food-safe solution than may be used in a variety of applications to control microorganisms in food plant operations, including the disinfection of food processing equipment as well as disinfection of the food product itself. The invention consists of a mixture of a salt, such as sodium chloride, with an acid and a surfactant, such as sodium lauryl sulfate. Suitable acids include citric, malic, acetic, propionic, lactic, benzoic, ascorbic, isoascorbic, sorbic, phosphoric, hydrochloric, malic, tartaric, adipic, succinic, glutaric, salicylic, and sulfuric acids as well as sodium bisulfate. The salt can be selected from inorganic salts including the sodium, potassium, magnesium, calcium, iron, and ammonium salts of chloride, sulfate, nitrate, phosphate, carbonate, and hydroxide. Suitable surfactants include sodium lauryl sulfate, linear alkylbenzene sulfonates, alcohol sulfates, alpha-olefin sulfonates, alcohol ethoxylates, nonylphenyl ethoxylates, alkylpolyglucosides, fatty alkanoamides, fatty amine oxides, sodium dioctylsulfosuccinate, dodecylbenzene sulfonic acid and its salts, the sodium salt of sulfonated oleic acid, sodium dodecylbenzene sulfonate, and dodecyldiphenyloxide- disulfonic acid and its salts.

A preferred formulation contains between 25 ppm and 25,000 ppm surfactant, between 0.1% acid and 25% acid, and between 72.5% and 99.9% salt. This blend can then be dissolved in water to make a solution ranging in concentration from about 1% total solids by weight up to the saturation point, which can be used as an antimicrobial solution for food safety applications.

Description of prior art The use of acids and surfactants as antibacterial agents is known. These cannot be used in environments where operation at low temperature is required, as their effectiveness drops off significantly at lower temperature and, of course, operation below 0°C is typically prevented by freezing.

Other antibacterial agents have been identified, but their use is problematic due to their non-food quality status. For example, a wide variety of chemical disinfecting agents are in use in food plants. However, there are often disadvantages to these chemicals. In some instances they are too toxic to come into direct contact with the food itself, and many present worker safety or environmental waste disposal issues. In other instances they are insufficiently effective to provide adequate kill of microorganisms, especially at low temperatures. Additionally, the relatively high cost of these chemicals adds to the cost of food production and, consequently, increases the cost of the end product itself.

Salt has been used for thousands of years as a food preservative.

Generally, however, salt solutions alone are not sufficiently effective as antibacterial agents, as they do not provide a speedy mechanism for killing unwanted bacteria that permits their exclusive use in food processing environments.

Thus, a problem associated with the antimicrobial solutions for food safety applications that precede the present invention is that they do not provide an improved antimicrobial solution for food safety applications having operating parameters adaptable to a multiplicity of applications in the food processing industry.

Another problem associated with the antimicrobial solutions for food safety applications that precede the present invention is that they do not provide an antimicrobial solution for food safety applications having safe, acceptable ingredients for use in food processing to prevent bacteria from accumulating in food processing operations.

Yet another problem associated with the antimicrobial solutions for food safety applications that precede the present invention is that they do not provide an antimicrobial solution for food safety applications that can be used at temperatures below room temperature, and preferably below the normal freezing point of water (0°C).

Still a further problem associated with the antimicrobial solutions for food safety applications that precede the present invention is that they may contain or lead to toxic and/or environmentally undesirable additives. For example, they may contain quaternary ammonium chloride as the anti-bacterial ingredient, or they may form chlorinated or brominated byproducts, or they may contain phosphates.

Yet another problem associated with the antimicrobial solutions for food safety applications that precede the present invention is that they do not provide an antimicrobial solution for food safety applications that is relatively inexpensive to purchase, use and maintain.

For the foregoing reasons, there has been defined a long felt and unsolved need for antimicrobial solutions for food safety applications that are comparatively inexpensive to use and maintain and are adaptable to accommodate a variety of operating conditions. In contrast to the foregoing, the present invention constitutes antimicrobial solutions for food safety applications that seek to overcome the problems discussed above while at the same time providing a simple, relatively easily implemented treatment and method that is readily adapted to a variety of applications.

SUMMARY OF THE INVENTION Early screening tests of a preferred embodiment revealed an unexpected, synergistic effect between sodium chloride and the acid/SLS (sodium lauryl sulfate) antimicrobial additive. Replicate tests were run to determine if this effect was significant. Solutions were also prepared containing an identical concentration of acid and SLS but no sodium chloride. Results of these tests run with multiple replicates illustrate that for both the citric acid/SLS and malic acid/SLS additives, the number of microorganisms remaining alive after 30 minutes is much lower when salt is present than when there is no salt present.

It is therefore an object of the present invention is to provide an improved antimicrobial solution for food safety applications.

Another object of the present invention is to provide an antimicrobial solution for food safety applications having acceptable ingredients for use in food processing to prevent microorganisms from accumulating in food processing operations.

Yet another object of the present invention is to provide an antimicrobial solution for food safety applications that can be used at temperatures below room temperature, and preferably below the normal freezing point of water (0°C).

Still a further object of the present invention is to provide an antimicrobial solution for food safety applications that does not rely on the presence of generally toxic or hazardous chemicals as the anti-microbial ingredient.

Still a further object of the present invention is to provide an antimicrobial solution for food safety applications that is relatively inexpensive to purchase, use and maintain.

For the foregoing reasons, there has been defined a long felt and unsolved need for an improved antimicrobial solution for food safety applications. The present invention provides an antimicrobial solution for food safety applications that seeks to overcome the problems discussed above.

DETAILED DESCRIPTION OF PRESENTLY PREFERRED EMBODIMENTS The use of acids and surfactants as antibacterial agents is known. Salt has also been used for thousands of years as a food preservative. However, it has been discovered that inorganic salts act synergistically with the acid/surfactant ingredients to provide a significant and unexpected increase in their antibacterial effectiveness.

Early screening tests indicated that there was an unexpected synergistic effect between sodium chloride and the acid/SLS (sodium lauryl sulfate) antibacterial additive. Replicate tests were run to determine if this effect was statistically significant.

Ten percent by weight solutions were prepared of a formula of 0.6% citric or malic acid, 100 ppm SLS, and 99.4% sodium chloride. Solutions were also prepared containing an identical concentration of acid and SLS but no sodium chloride. A bacterial culture suspension (Esclaerichia coli ATCC 11229) that had been incubated for 24 hours in Brain Heart Infusion (BHI) broth and had an initial inoculum count of about 109 CFU/ml was serially diluted in cold Butterfield's Phosphate Buffered Water (BPBW) to 105 CFU/ml. A 1.0 ml aliquot of this suspension was added to 100 ml of test solution at room temperature and mixed well, providing an initial inoculum of 103 CFU/ml. After 30 minutes, the E. coli populations were enumerated by plating on tryptic soy agar (TSA), making serial dilutions as necessary in BPBW. Plates were incubated at 35°C +/- 2°C for approximately 24 hours. Colonies were then counted and compared to the initial inoculum counts. Results of these tests run on 16 replicates of each test solution are given in Table 1.

Table 1. Effectiveness of Acid/SLS Solutions with and without Salt on E. coli Test Solution Average Conc. of E. Coli (CFU/ml) citric acid, SLS, with salt 540 citric acid, SLS, without salt 1054 malic acid, SLS, with salt 141 malic acid, SLS, without salt 2419 It can be seen that for both the citric acid/SLS and malic acid/SLS additives, the number of bacteria remaining alive after 30 minutes is much lower when salt is present than when there is no salt present. Analysis of the data indicates that there is a statistically significant increase in kill in the presence of salt (p<0.05). In contrast, a 10% solution of pure sodium chloride does not provide any significant kill of the test microorganisms.

The fact that these formulas contain a substantial concentration of salt makes them ideal for a variety of applications. For instance, they are ideal for chilling brine applications. Chilling brines make use of concentrated salt solutions that depress the freezing point of the solution to provide a low temperature bath or shower in which food products can be efficiently cooled. Bacterial contamination of the chill brine is a food safety hazard, requiring that the brine be frequently disposed and often requiring rigorous cleaning of the equipment to remove bacterial biofilms. Contamination by Listeria mo710cytogenes is of particular concern in many ready-to-eat meat, poultry, seafood and dairy processing chill brine applications because it is known to survive in high salt concentrations and because many of the currently available disinfectant chemicals are either not suitable for direct food contact or become ineffective at the cold temperatures of the chill bath. Brine chillers are used extensively to cool frankfurters and other sausage products in continuous-cook operations. Dozens of nationwide recalls and at least one large food-borne outbreak have been caused by L. naoraocytoge7les contamination of these types of products.

Tests were run on 17% by weight solutions of formulas consisting of between 0.3% and 6.0% citric acid, between 50 and 500 ppm SLS, and between 94% and 99.7% sodium chloride. Test solutions were cooled to-6. 7°C and inoculated with several strains of L. rszonocytogenes. Within 4 hours most solutions showed a 3 log kill of microorganisms and within 24 hours nearly all solutions showed 100% kill of the inoculum. A brine solution made up of sodium chloride alone caused less than a 1 log reduction of the L. monocytogeraes over a 24-hour period.

Many applications for these formulas are envisioned. One application is for a disinfecting meat bath/rinse. Bacterial contamination during slaughter is typically highest at the surface of the meat, and these solutions may be used as a method to kill bacteria directly on the meat surface in a manner that is food safe and will impart no toxic chemicals to the meat. A solution of the antimicrobial salt could be sprayed or showered on to animal carcasses or the carcasses could be directly immersed in a bath of the solution. The brine could be pre-chilled to provide a simultaneous cooling and disinfection. The antimicrobial brine can also be used to wash animals prior to slaughter, to minimize contamination from the animals'hides, skins or feathers. It can also be used as a disinfection wash/chill step for beef trim.

Another application for this invention is for beef injection brines. Brines are injected into enhanced beef products, and there is concern that the brine may drive bacteria, such as E. coli 0157: H7, from the surface into internal areas of the meat.

Cooking intact cuts of beef to rare or medium-rare doneness could then lead to food- borne illness. Another concern is that the brine, which is recycled in the process, will become contaminated. Under the current regulatory environment, it is crucial that beef processors are able to prove lot-to-lot separation. Use of a validated antimicrobial in the injected brine solution could prevent the brine injection system from tying together multiple production lots. Other potential uses in the meat industry include hide curing, offal chilling and natural casing preservation.

In the poultry industry, contamination of the carcasses by Salmonella spp. and Campylobacter spp. is a major public health concern. An antimicrobial salt solution could be used in poultry chill tanks to reduce this contamination and provide an energy- efficient cooling step, thus improving product shelf life and quality.

Brines used in cheese manufacture present another application for this invention. Cheese manufacture often involves a prolonged soak in concentrated brine.

This step can introduce a significant risk for L. fraofzocyotogenes contamination. This risk could be minimized through the use of an antimicrobial salt solution in the brine.

Yet another application is as a wash to kill salmonella on eggs. Also, hard-boiled eggs are often pre-disinfected and shipped in brine. Use of these formulas would permit the disinfection step to be carried out in the storage brine itself. Yet another application is a wash to disinfect produce, which can become contaminated with salmonella and other pathogenic bacteria in the field.

The following examples further illustrate the synergistic and unexpected results from combining acid/surfactant with salt. An experiment was run to determine if solutions containing sodium chloride, sodium lauryl sulfate, and various acids would kill L. monocytogenes at cold temperatures. The following test procedure was used: A bacterial culture suspension (L. naoraocytogenes H2446 [CDC Global Standard] ; Scott A- serotype 4b; 12243-serotype 1/2a ; and a recent cooked meat and poultry facility isolate, WP4) that had been incubated for at least 5 days in BHI broth and had an initial inoculum count of about 109 CFU/ml was serially diluted in cold BPBW to 105 CFU/ml.

A 1.0 ml aliquot of this suspension was added to 100 ml of cold (-7°C +/-2°C) test solution and mixed well, providing an initial incoculum of 103 CFU/ml. The test solutions were incubated at-7°C +/-2°C for the duration of the experiment. At intervals of 0,4, and 24 hours the L. naoTaocytoge7aes populations in the test solutions were determined on Modified Oxford agar (MOX). MOX plates were incubated at 35°C +/- 2°C for approximately 48 hours. Colonies were then counted and compared to the initial inoculum counts.

Results are given in Table 2. Each test solution was a 17% by weight solution of the listed formula prepared in soft water.

Table 2. Effect of Solutions of NaCl, SLS and various acids on L. monocytogenes Sample Time 0 4 hr 24 hr pH Water CFU/ml CFU/ml CFU/ml Activity 100% NaCl 1550 1250 1170 7. 88 0.88 2.0% Malic Acid, 500 ppm SLS, 98.0% NaCl 0 0 1. 21 ND 5.0% Na Bisulfate, 500 ppm SLS, 95.0% NaCl 0 0 0. 81 0.883 Water Control 127040009. 34 0.999 0.3% Malic Acid, 100 ppm SLS, 99.7% NaCl 480 5 0 4. 1 ND 0.5% Malic Acid, 100 ppm SLS, 99.5% NaCI 176 0 0 3. 31 ND 0.7% Malic Acid, 100 ppm SLS, 99.3% NaCl 117 0 0 2. 99 0.88 0.3% Citric Acid, 500 ppm SLS, 99.7% NaCl 5 0 0 4. 14 ND 0.5% Citric Acid, 500 ppm SLS, 99.5% NaCl 0 0 0 3. 37 ND 0.7% Citric Acid, 500 ppm SLS, 99.3% NaCl 0 0 0 2. 98 0.88 0.3% Malic Acid, 500 ppm SLS, 99.7% NaCl 11 0 4. 15 ND 0.5% Malic Acid, 500 ppm SLS, 99.5% NaCI 3 0 0 3. 39 ND 0.7% Malic Acid, 500 ppm SLS, 99.3% NaCl 0 0 3. 06 0.879 1.0% Citric Acid, 500 ppm SLS, 99.0% NaCl 0 0 0 2. 69 ND 1.0% Malic Acid, 500 ppm SLS, 99.0% NaCl 0 0 2. 81 ND 2.0% Lactic Acid, 500 ppm SLS, 98.0% NaCl 0 0 0 2. 65 0.885 2.0% Phosphoric Acid (75%), 500 ppm SLS, 0 1. 52 0.884 98.0% NaCl 1.0% Benzoic Acid, 500 ppm SLS, 99.0% 0 0 0 3.93 0.879 NaCl 2.0% Citric Acid, 500 ppm SLS, 98.0% NaCl 0 0 0 2.3 0. 884 2.0% Malic Acid, 500 ppm SLS, 98.0% NaCl 0 0 0 2. 46 0. 882 In another experiment, 17% by weight solutions of formulas containing various levels of sodium chloride, citric acid, and sodium lauryl sulfate were tested for effectiveness in killing L. monocytogeiies at cold temperatures. The same test procedure was used as described above, except test solutions were plated on MOX with a Thin Agar Overlay of TSA (to aid in the recovery of injured cells). Results are given in Table 3. The data indicate that the relative amounts of acid and surfactant can be varied to suit different applications. In pH sensitive applications, the acid may be decreased without losing effectiveness if the level of surfactant is increased. Similarly, in applications where a lower level of surfactant is desired, the performance can be maintained by raising the concentration of acid.

Table 3. Effect of Solutions of NaCl, SLS, and Citric Acid on L. morzocytogenes at-6. 7°C Sample Time 0 4 hr 24 hr pH CFU/ml CFU/ml CFU/ml 100% NaCl-7000-6250 2290 7.66 0. 3% Citric Acid, 50 ppm SLS, 99. 7% NaCl #4940 163 0 4.19 0. 3% Citric Acid, 100 ppm SLS, 99. 7% NaCl 2230 97 0 4. 27 0. 3% Citric Acid, 150 ppm SLS, 99. 7% NaCl 3080 105 0 4. 3 0. 3% Citric Acid, 200 ppm SLS, 99. 7% NaCl 1970 42 0 4. 28 0. 3% Citric Acid, 300 ppm SLS, 99. 7% NaCl 1490 20 0 4. 3 0. 3% Citric Acid, 400 ppm SLS, 99. 7% NaCl 221 1 0 4. 29 0. 3% Citric Acid, 500 ppm SLS, 99. 7% NaCI 99 0 0 4. 32 0. 5% Citric Acid, 50 ppm SLS, 99. 5% NaCl 3360 0 0 3. 54 0. 5% Citric Acid, 100 ppm SLS, 99. 5% NaCI 3180 1 0 3. 54 0. 7% Citric Acid, 50 ppm SLS, 99. 3 % NaCl 3710 0 3. 14 0. 7% Citric Acid, 100 ppm SLS, 99. 3% NaCl 1020 0 0 3. 13 1.0% Citric Acid, 50 ppm SLS, 99.0% NaCl 1840 0 0 2. 82 1.0% Citric Acid, 100 ppm SLS, 99.0% NaCl 970 0 0 2. 82 2. 0% Citric Acid, 50 ppm SLS, 98. 0% NaCl 114 0 0 2. 41 2. 0% Citric Acid, 100 ppm SLS, 98. 0 % NaCl 479 0 2. 41 4. 0% Citric Acid, 50 ppm SLS, 96. 0% NaCl 6 0 0 2. 12 4. 0% Citric Acid, 100 ppm SLS, 96. 0% NaCI1002. 12 6. 0% Citric Acid, 50 ppm SLS, 94.0% NaCl 0 1. 99 In another experiment, two sets of solutions were tested. The first set (samples 1-12 in Table 4 below) was prepared in hard tap water and contained about 17.0% by mass of the formulation. These samples were inoculated with 103 CFU/ml L. monocytogenes by the same procedure as described above. A second set of samples was prepared from brine taken from a ready-to-eat meat processing operation. The recirculated brine had been used to chill packaged meat for one week. After a week of use the brine typically contains various types of aerobic psychrotrophic and mesophilic bacteria. This experiment was done in order to determine if the additives would kill the microorganisms naturally occurring in actual process brine from a plant. Since the spent chill brine samples already contained NaCl, citric acid and/or SLS was added to provide an effective concentration of additive. One set of these samples (samples 13-17) were inoculated with 103 L. moiiocytogeiies and the other set (samples 18-22) contained only the naturally occurring organisms in the spent chill brine. Results are given in Table 4 below. The data indicate that at lower acid levels, the SLS increases the effectiveness of the mixture, but at higher acid levels, the SLS is not necessary. The results show the formulations are effective in hard water. The results also demonstrate that the formulations effectively kill L. mo7Zocytoge7zes as well as the naturally occurring microorganisms in spent chill brine from an actual meat processing plant.

Table 4. Effects of Antimicrobial Salt Formulas in Hard Water and in Spent Chill Brine Sample Time 0 2 hr 24 hr cfu/ml cfu/ml cfu/ml 100% NaCl 760 1100 1100 0.3% Citric Acid, 100 ppm SLS, 99.7% NaCl 730 670 29 0.3% Citric Acid, 99.7% NaCl 1460 1330 830 0.5% Citric Acid, 100 ppm SLS, 99.5% NaCl 890 240 0 0.5% Citric Acid, 99.5% NaCl 1060 1170 330 0.7% Citric Acid, 100 ppm SLS, 99.3% NaCl 1010 14 0 0.7% Citric Acid, 99.3% NaCl 1040 1030 3 1.0% Citric Acid, 100 ppm SLS, 99. 0% NaCl 840 0 0 1.0% Citric Acid, 99.0% NaCl 990 340 0 2.0% Citric Acid, 98.0% NaCl 910 0 0 4.0% Citric Acid, 96. 0% NaCl 1110 0 0 6.0% Citric Acid, 94.0% NaCl 950 0 0 Sample Time 0 2 hr 24 hr cfu/ml cfu/ml cfu/ml Brine Control with L. mono 1260 1290 600 1% Citric Acid in Brine with L. mono 1050 0 0 2% Citric Acid in Brine with L. mono 1140 0 0 1% Citric Acid + 50 ppm SLS in Brine with L. mono 1090 0 0 2% Citric Acid + 50 ppm SLS in Brine with L. mono 1070 0 0 Brine Control 6000 3100 2000 1% Citric Acid in Brine 2490 190 4 2% Citric Acid in Brine 1670 6 0 1% Citric Acid + 50 ppm SLS in Brine 2520 122 0 2% Citric Acid + 50 ppm SLS in Brine 1480 6 0 A test was run to determine if salts other than sodium chloride would show a synergistic antimicrobial effect with an acid and sodium lauryl sulfate. Solutions containing 0.6409 grams malic acid and 0.0107 grams sodium lauryl sulfate per liter were prepared with and without 107.0 grams of various salts (added on an anhydrous basis). Solutions were inoculated with E. coli as described above and the amount of bacterial kill was measured to determine if the added salt caused an increase in the effectiveness of the acid/surfactant active ingredients. Results are shown in Table 5.

Table 5. Effect of Different Salts on the Antimicrobial Action of Malic Acid/SLS Solution (salt added) % Kill of E. Coli No salt addition 4.4% Sodium sulfate 87% Magnesium chloride 56% Potassium chloride 18% Sodium chloride 78% Potassium sulfate 34% Calcium chloride 55% Magnesium sulfate 93% Tests run on solutions containing only the salt and no other ingredient indicate that sodium sulfate, potassium chloride and potassium sulfate provide no bacterial kill. Magnesium chloride solution provided 61% kill, calcium chloride provided 26% kill, and magnesium sulfate provided 10% kill. Thus, based on the data developed thus far, sodium sulfate, sodium chloride, and magnesium sulfate appear to significantly increase the effectiveness of the acid/surfactant antimicrobial agent, even though the salts provide little kill on their own.

The effectiveness of antimicrobial salt formulas was tested against L. mo7Zocytoge72es in a biofilm. Stainless steel coupons (2 x 5 cm, type 302 stainless steel, 2B finish) were cleaned in acetone followed by an alkaline detergent and distilled water and then dried in an autoclave at 121°C for 15 minutes. A culture of L. rraonocytogefaes (Scott A-serotype 4b) was prepared by inoculating 10 mL of TSA and incubating overnight at 35°C. 50 mL of sterile TSA + 0.6% yeast extract (YE) was aseptically dispensed into sterile disposable conical shaped plastic tubes and one drop of overnight grown L. nioizo culture was added to each tube. Inoculated tubes were incubated at 25°C for approximately 48 hours. After the biofilm had formed on the coupons, a coupon was aseptically removed from the tube and gently rinsed with distilled water to remove unattached cells. Coupons were then immersed in cold antimicrobial test solution (- 6. 7°C) and incubated over different time intervals (1 hour, 24 hours, and 5 days). After incubation period, the coupon was shaken in a tube containing 40 mL of sterile PBW and 10 sterile glass beads (4 mm) for 2 minutes two remove the cells attached to the coupon biofilm. The cells were plated in the PBW on TSA + 0.6% YE using appropriate dilutions and incubated at 35°C for 48 hours.

Results on triplicate samples of antimicrobial test solutions are given in Table 6 below. Each solution contained 17% by weight of a formula consisting of the percentages of citric acid and SLS listed in Table 6, with the balance of the formula being NaCl in each case. The data indicate that not only are the antimicrobial salt solutions effective at killing bacteria suspended in solution, they are also effective at killing bacteria within a biofilm.

Table 6. Log Concentration of L. MO7tO in Antimicrobial Salt Solutions Sample 1 Hour 24 Hours 5 days 0.3% citric acid, 100-5. 08 4.59 1.38 ppm SLS 0. 3% citric acid, 100-4. 90 3.85 1.79 ppm SLS 0.3% citric acid, 100-4. 81 3.48 1.92 ppm SLS 0. 3% citric acid, 500 4. 81 4. 76 2. 23 ppm SLS 0. 3% citric acid, 500 4. 90 3. 48 2. 18 ppm SLS 0.3% citric acid, 500-5. 18 3.48 2.36 ppm SLS 0.7% citric acid, 100 1.88 0 0 ppm SLS 0. 7% citric acid, 100 2. 02 0 0 ppm SLS 0.7% citric acid, 100 1.28 0 0 ppm SLS 0.7% citric acid, 500 0.70 1.00 0.90 ppm SLS 0. 7% citric acid, 500 0.90 0.70 0.30 ppm SLS 0. 7% citric acid, 500 0.85 0 0 ppm SLS 2.0% citric acid, 100 0 0 ND ppm SLS 2.0% citric acid, 100 0 0 ND ppm SLS 2.0% citric acid, 100 0 0 ND ppm SLS 2.0% citric acid, 500 0 0 ND ppm SLS 2.0% citric acid, 500 0 0 ND ppm SLS 2. 0% citric acid, 500 0 0 ND ppm SLS 6.0% citric acid, 100 0 0 ND ppm SLS 6.0% citric acid, 100 0 0 ND ppm SLS 6.0% citric acid, 100 0 0 ND ppm SLS Sample 1 Hour 24 Hours 5 days 6.0% citric acid, 500 0 0 ND ppm SLS 6.0% citric acid, 500 0 0 ND ppm SLS 6.0% citric acid, 500 0 0 ND ppm SLS 12.0% citric acid, 0 0 ND 100 ppm SLS 12.0% citric acid, 0 0 ND 100 ppm SLS 12.0% citric acid, 0 0 ND 100 ppm SLS 12.0% citric acid, 0 0 ND 500 ppm SLS 12.0% citric acid, 0 0 ND 500 ppm SLS 12.0% citric acid, 0 0 ND 500 ppm SLS Salt Control A-5. 04-7. 15 7. 65 SaltControlB-5. 48-7. 157. 42 Salt Control C-5. 48-7. 11 7. 65 . Water Control ~5. 18 ~7. 18 7. 54 Another set of experiments was done in order to determine the effectiveness of different acids and different types of surfactants in the antimicrobial salt formulations. In one experiment, test solutions containing 17% by weight of formulas containing various levels of sodium chloride, 100 ppm sodium lauryl sulfate, and various levels of different acids were tested for effectiveness in killing L. monocytogenes at cold temperatures. The same test procedure was used as described above (test solutions were plated on MOX TAL (Modified Oxford Medium with a Thin Agar Layer) with TSA).

Results are given in Table 7.

Table 7. Effect of Different Acids on the Antimicrobial Action of NaCl/Acid/SLS Sample Time 0 (CFU/ml) Time 4 Hours (CFU/ml) Salt control 850 1380 Salt + 100 ppm SLS 980 890 0.5% citric acid, 100 ppm SLS, 99.5% NaCl 1230 18 0.9% succinic acid, 100 ppm SLS, 99. 1% NaCl 1070 69 1.5% isoascorbic acid, 100 ppm SLS, 98.5% NaCl 1140 59 1.8% adipic acid, 100 ppm SLS, 98.2% NaCl 900 4 1.6% sorbic acid, 100 ppm SLS, 98.4% NaCl 820 500 1.3% acetic acid, 100 ppm SLS, 98.7% NaCl 1070 230 2. 1% propionic acid, 100 ppm SLS, 97.9% NaCl 1440 6 0.6% lactic acid, 100 ppm SLS, 99.4% NaCl 1050 220 1.6% ascorbic acid, 100 ppm SLS, 98.4% NaCl 1230 54 0.3% formic acid, 100 ppm SLS, 99.7% NaCl 1930 38 0.3% phosphoric acid, 100 ppm SLS, 99.7% NaCl 1050 17 0. 1 % hydrochloric acid, 100 ppm SLS, 99.9% NaCl 1100 44 0.3% tartaric acid, 100 ppm SLS, 99.7% NaCI 1180 410 1. 1% glutaric acid, 100 ppm SLS, 98.9% NaCl 610 180 1.2% benzoic acid, 100 ppm SLS, 98.8% NaCl 1020 17 0.5% salicylic acid, 100 ppm SLS, 99. 5% NaCI 1100 5 0.2% sulfuric acid, 100 ppm SLS, 99. 8% NaCl 830 0 In another experiment, test solutions containing 17% by weight of formulas containing 99.7% sodium chloride, 0.3% citric acid, and 500 ppm of various types of surfactants were tested for effectiveness in killing L. rnonocytogenes at cold temperatures. The same test procedure was used as described above (test solutions were plated on MOX TAL (Modified Oxford Medium with a Thin Agar Layer) with TSA).

Results are given in Table 8.

Table 8. Effect of Different Acids on the Antimicrobial Action of NaCl/Acid/SLS Surfactant Tested Time 0 (CFU/ml) Time 4 Hours (CFU/ml) Salt Control (no additive) 880 610 polyoxyethylene-polyoxypropylene block polymer 820 610 sodium salt of sulfonated oleic acid 240 0 sodium xylene sulfonate 910 820 dodecyl diphenyl oxide 0 0 disulfonate sodium linear alkyl- benzene sulfonate 490 0 alpha-olefin sulfonate 370 0 alkylpolyglucoside 280 0 nonylphenol ethoxylate 460 0 fatty alkanolamide 470 0 alcohol ethoxylate 1080 1 lauramine oxide 2 0 As presently under development, especially preferred embodiments of the antimicrobial formulations can be operated under two sets of conditions. In one, a chilling brine is maintained at a temperature of about-3. 9°C is employed. The chilling brine comprises between about 0.3% and about 1.0% citric acid. The citric acid concentration may be increased to as high as about 2.0%. Between about 100 and about 500 ppm SLS is utilized. The balance of the brine formulation is NaCl, and the formulation is mixed with water to a solution of about 9% to about 12%. In another chilling brine application, a chilling brine is maintained at a temperature of about-6. 7°C.

The chilling brine comprises between about 0.3% and about 1.0% citric acid. Again, the citric acid concentration may be increased to as high as about 2.0%. Between about 100 and about 500 ppm SLS is utilized. The balance of the brine formulation is NaCl, and the formulation is mixed with water to a solution of about 15% to about 17%.

Thus, the data indicate that solutions of salt, acid, and surfactant provide efficient kill of bacteria even at temperatures below the freezing point of water. Salts such as sodium sulfate, sodium chloride, and magnesium sulfate act synergistically with the acid and surfactant to enhance the antimicrobial effectiveness. The formulations are shown to be effective in killing pathogenic bacteria such as L. monocytogenes. The formulas were shown to be effective both in freshly prepared brines and in actual spent process chill brine from a ready-to-eat meat plant. The levels of acid and surfactant may be varied to suit the particular application; reducing the concentration of the acid may be compensated by raising the concentration of surfactant and vice versa. In addition to effectively killing bacteria suspended in solutions, the formulas are also shown to be effective at killing bacteria within a biofilm.

While in the foregoing specification this invention has been described in relation to certain preferred embodiments thereof, and many details have been set forth for purpose of illustration, it will be apparent to those skilled in the art that the invention is susceptible to additional embodiments and that certain of the details described herein can be varied considerably without departing from the basic principles of the invention.